ArticleJournal of clinical medicine2026

Evidence That Semaglutide Represents an Important Tool for Treatment of Irregular Menses and Chronic Anovulation in Women with Polyendocrine Metabolic Ovarian Syndrome.

Enrico Carmina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.